After completing this activity, pharmacists should be able to:
- Describe the link between overweight and obesity and type 2 diabetes
- Outline the evidence for the benefits of lifestyle interventions, including weight loss, in the management of type 2 diabetes
- List medications associated with weight gain that may have impacts in patients with type 2 diabetes
2016 Competency Standards: 3.2, 3.5, 3.6
Accreditation number: A2009RP2 Accreditation expires: 31/08/2022
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.